Diana van Stijn

Lapsi Health., USA

Pediatric resident / Founder & Chief Medical Officer

Diana van Stijn, Chief Medical Officer, Lapsi Health, Synchronized Swimmer, Dutch National Team, Paediatrician, Amsterdam, The Netherlands Diana van Stijn M.D. Ph.D is a pediatric resident who works at the Amsterdam UMC, The Netherlands. Dr. van Stijn is the co-founder and Chief Medical Officer of Lapsi Health, a Digital Biomarker development company located in The Netherlands. She is the lead of Innovation and Medical strategy of the company, creating new digital biomarkers that will reshape clinical decision making, support patient empowerment and enable proper digital clinical research. She is also a leading expert on digital therapeutics (DTx) and is a faculty member of the DTxcellence program, a first of its kind digital education initiative for medical and non-medical professionals that want to learn Digital Therapeutics and other important concepts of Digital Health. Dr. van Stijn received her Ph.D. in Pediatrics investigating Kawasaki disease and the COVID-related new emerging pediatric disease called MIS-C. Dr. van Stijn believes in the democratization of healthcare and the empowerment of women in Healthcare and Health-Tech.

Dr Adam Landman

Brigham and Women's Hospital., USA

CIO & Emergency Physician

Dr Adam Landman, Vice President, Chief Innovation Officer, Digital Innovation Officer, Brigham and Women’s Hospital, Boston, Massachusetts As Brigham and Women's Hospital's Vice President, Chief Information and Digital Officer, Adam Landman, MD, MS, MIS, MHS, is responsible for maintaining a focus on excellence while developing system-wide strategic IT initiatives, with the goal of evolving the next generation of information systems across the BH enterprise. Landman is board certified in Emergency Medicine and Clinical Informatics. He joined BWH in 2010 as director of Clinical Information in the Department of Emergency Medicine, where he led the project to move BWH ED clinicians from paper-based to electronic documentation. He also led the team that built the CliniCam mobile app, a secure and convenient image sharing app for acquiring digital images and storing them in the electronic health record, which was made available for all clinical users in the hospital. He previously served the hospital as the chief medical information officer for Health Information Innovation & Integration, where he oversaw a range of BH PeC responsibilities, such as the local implementation of the Sunquest laboratory information system and integration with Epic, with a novel positive patient identification specimen collection solution that has reduced laboratory specimen errors for inpatients. He had also been driving efforts at both the local and industry levels to improve the experience of hospital patients and visitors, strengthening the innovation culture at BWHC through programs like the Innovation Hub, and collaborating with external digital health companies and start-ups. Landman received his MD from the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and trained in Emergency Medicine at UCLA Medical Center. He was a Robert Wood Johnson Foundation Clinical Scholar at Yale University, where he also received his masters of Health Sciences. He completed graduate degrees in Information Systems and Health Care Policy and Management at Carnegie Mellon University.

Dr Arash Naeim

Clinical Research at UCLA Health., USA

Chief Medical Officer

Arash Naeim M.D. Ph.D is a Professor of Medicine and Bioengineering which specialized training in Geriatrics, Hematology-Oncology, and Clinical Informatics. He serves Chief Medical Officer for Clinical Research at UCLA Health and Co-Director for the UCLA Center for Smart Health as well as the Co-Director of the UCLA Clinical and Translational Institute, Senior Leader of the Jonsson Comprehensive Cancer Center, Associate Director for the Institute for Precision Health, and Associate Director of the Garrick Institute for Risk Science. He holds the Neria and Manizheh Yomtoubian Endowed Chair in Cancer and Risk Sciences. He is the UCLA site PI on a large PCORI Pragmatic Trial called WISDOM exploring precision health personalized risk-based breast cancer screening, designed UCLA's strategy to consent 150,000 individuals to participate in precision health as part of the ATLAS project, and has been exploring the use of wearable sensors in assessing and monitoring older at-risk patient populations. He received a B.S. in Biochemistry and his M.D from UCLA and received his Ph.D. in Public Policy from the RAND Corporation.

Dr Eric Eskioglu

Novant Health., USA

EVP - Chief Medical & Scientific Officer

Dr Eric Eskioglu, Executive Vice President, Chief Medical and Scientific Officer, Novant Health, Charlotte, North Carolina Eric Eskioglu, MD, is executive vice president and chief medical and scientific officer for Novant Health. He oversees our medical staff systemwide, as well as safety and quality initiatives and programs supporting clinical variation reduction, pharmacy, and healthcare economics. He provides strategic clinical and cultural leadership to ensure the delivery of high-quality, cost-effective, and patient-centered care across the Novant Health system. Dr. Eskioglu co-leads the Novant Heath Institute of Innovation & Artificial Intelligence and is a practicing vascular neurosurgeon. He previously served as the senior vice president of neurosciences for Novant Health. Dr. Eskioglu has a unique aerospace engineering background combined with his clinical neurosurgical experience. Prior to his career in medicine, he was an aerospace engineer at AlliedSignal Aerospace Company and Boeing. Before joining Novant Health, Dr. Eskioglu worked at Physicians Regional Healthcare System in Naples, Florida, and served as a neurosurgeon physician executive at Health Management Associates. There he established the region’s first comprehensive stroke center. Dr. Eskioglu has also served as the medical director for endovascular/vascular neurosurgery at Lee Health in Fort Myers, Florida. He began his neurosurgical career at Vanderbilt University medical school as an assistant professor of neurological surgery. A native of Tucson, Arizona, Dr. Eskioglu earned a Bachelor of Science in Aerospace and Mechanical Engineering from the University of Arizona. He received his medical degree, with Alpha Omega Alpha Medical Society honors, from the University of Kansas Medical School. Dr. Eskioglu was the first inaugural Fellow at the National Institutes of Health with Pfizer Clinical Research Scholars program in Bethesda, Maryland. He completed his neurosurgery residency at Vanderbilt University Medical Center, and an additional endovascular/vascular neurosurgery fellowship at the University of Florida Health Hospital. He is certified by the American Board of Neurological Surgery and a Fellow of the American Association of Neurological Surgeons.

Elon Musk

Acme corp.

Executive Director, Global Head ofTechnical &Scientific Affairs for Pharma Services

...

Bill Gates

Acme corp.

Executive Director, Global Head ofTechnical &Scientific Affairs for Pharma Services

...

Elon Musk

Acme corp.

Executive Director, Global Head ofTechnical &Scientific Affairs for Pharma Services

...

Bill Gates

Acme corp.

Executive Director, Global Head ofTechnical &Scientific Affairs for Pharma Services

...